158 related articles for article (PubMed ID: 9401788)
1. Effect of lacidipine on cholesterol esterification: in vivo and in vitro studies.
Bernini F; Canavesi M; Bernardini E; Scurati N; Bellosta S; Fumagalli R
Br J Pharmacol; 1997 Nov; 122(6):1209-15. PubMed ID: 9401788
[TBL] [Abstract][Full Text] [Related]
2. Calcium antagonists and cholesteryl ester metabolism in macrophages.
Bernini F; Bellosta S; Didoni G; Fumagalli R
J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S42-5. PubMed ID: 1725002
[TBL] [Abstract][Full Text] [Related]
3. The antiatherosclerotic effects of calcium antagonists.
Paoletti R; Bernini F; Corsini A; Soma MR
J Cardiovasc Pharmacol; 1995; 25 Suppl 3():S6-10. PubMed ID: 8852538
[TBL] [Abstract][Full Text] [Related]
4. Lacidipine [correction of Lalsoacidipine] modulates the secretion of matrix metalloproteinase-9 by human macrophages.
Bellosta S; Canavesi M; Favari E; Cominacini L; Gaviraghi G; Fumagalli R; Paoletti R; Bernini F
J Pharmacol Exp Ther; 2001 Mar; 296(3):736-43. PubMed ID: 11181900
[TBL] [Abstract][Full Text] [Related]
5. Effects of lacidipine on experimental models of atherosclerosis.
Bernini F; Corsini A; Raiteri M; Soma MR; Paoletti R
J Hypertens Suppl; 1993 Mar; 11(1):S61-6. PubMed ID: 8483025
[TBL] [Abstract][Full Text] [Related]
6. Pleiotropic effects of statins in atherosclerosis and diabetes.
Bellosta S; Ferri N; Arnaboldi L; Bernini F; Paoletti R; Corsini A
Diabetes Care; 2000 Apr; 23 Suppl 2():B72-8. PubMed ID: 10860194
[TBL] [Abstract][Full Text] [Related]
7. Effect of the ACAT inhibitor, HL-004, on cholesterol metabolism in macrophages.
Murakami S; Yamagishi I; Asami Y; Sato M; Tomisawa K
Cell Mol Biol (Noisy-le-grand); 1996 Sep; 42(6):865-72. PubMed ID: 8891354
[TBL] [Abstract][Full Text] [Related]
8. Direct effect of an acyl-CoA:cholesterol acyltransferase inhibitor, F-1394, on atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice.
Chiwata T; Aragane K; Fujinami K; Kojima K; Ishibashi S; Yamada N; Kusunoki J
Br J Pharmacol; 2001 Aug; 133(7):1005-12. PubMed ID: 11487509
[TBL] [Abstract][Full Text] [Related]
9. [Effect of the monooxygenase activity inhibitor ketoconazole on cholesterol esterification in mouse peritoneal macrophages].
Dushkin MI; Mandrikova EV; Liubimov GIu; Vol'skiĭ NN; Dolgov AV
Biokhimiia; 1990 Sep; 55(9):1607-15. PubMed ID: 2078637
[TBL] [Abstract][Full Text] [Related]
10. Expression of scavenger receptor BI facilitates sterol movement between the plasma membrane and the endoplasmic reticulum in macrophages.
Huang ZH; Gu D; Lange Y; Mazzone T
Biochemistry; 2003 Apr; 42(13):3949-55. PubMed ID: 12667086
[TBL] [Abstract][Full Text] [Related]
11. Anti-atherosclerotic activity of the calcium antagonist lacidipine in cholesterol-fed hamsters.
Cristofori P; Lanzoni A; Gaviraghi G; Turton J; Sbarbati A
Biomed Pharmacother; 2000 Mar; 54(2):93-9. PubMed ID: 10759293
[TBL] [Abstract][Full Text] [Related]
12. Impaired mobilisation of cholesterol from stored cholesteryl esters in human (THP-1) macrophages.
Graham A; Angell AD; Jepson CA; Yeaman SJ; Hassall DG
Atherosclerosis; 1996 Feb; 120(1-2):135-45. PubMed ID: 8645354
[TBL] [Abstract][Full Text] [Related]
13. Uptake of dexamethasone incorporated into liposomes by macrophages and foam cells and its inhibitory effect on cellular cholesterol ester accumulation.
Chono S; Morimoto K
J Pharm Pharmacol; 2006 Sep; 58(9):1219-25. PubMed ID: 16945180
[TBL] [Abstract][Full Text] [Related]
14. [The effect of verapamil and nifedipine on cholesterol esterification and accumulation in macrophages].
Dushkin MI; Ivanova MV
Eksp Klin Farmakol; 1992; 55(3):37-9. PubMed ID: 1458160
[TBL] [Abstract][Full Text] [Related]
15. The effect of acyl CoA: cholesterol acyltransferase inhibition on the uptake, esterification and secretion of cholesterol by the hamster small intestine.
Burrier RE; Smith AA; McGregor DG; Hoos LM; Zilli DL; Davis HR
J Pharmacol Exp Ther; 1995 Jan; 272(1):156-63. PubMed ID: 7815329
[TBL] [Abstract][Full Text] [Related]
16. Calcium, calcium antagonists and experimental atherosclerosis.
Paoletti R; Corsini A; Soma MR; Bernini F
Blood Press Suppl; 1996; 4():12-5. PubMed ID: 8973776
[TBL] [Abstract][Full Text] [Related]
17. Tamoxifen is a potent inhibitor of cholesterol esterification and prevents the formation of foam cells.
de Medina P; Payré BL; Bernad J; Bosser I; Pipy B; Silvente-Poirot S; Favre G; Faye JC; Poirot M
J Pharmacol Exp Ther; 2004 Mar; 308(3):1165-73. PubMed ID: 14617686
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology of the ACAT inhibitor avasimibe (CI-1011).
Llaverías G; Laguna JC; Alegret M
Cardiovasc Drug Rev; 2003; 21(1):33-50. PubMed ID: 12595916
[TBL] [Abstract][Full Text] [Related]
19. Glibenclamide acts as an inhibitor of acyl-CoA:cholesterol acyltransferase enzyme.
Ohgami N; Kuniyasu A; Furukawa K; Miyazaki A; Hakamata H; Horiuchi S; Nakayama H
Biochem Biophys Res Commun; 2000 Oct; 277(2):417-22. PubMed ID: 11032738
[TBL] [Abstract][Full Text] [Related]
20. Androgen-mediated cholesterol metabolism in LNCaP and PC-3 cell lines is regulated through two different isoforms of acyl-coenzyme A:Cholesterol Acyltransferase (ACAT).
Locke JA; Wasan KM; Nelson CC; Guns ES; Leon CG
Prostate; 2008 Jan; 68(1):20-33. PubMed ID: 18000807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
